{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:08:43Z","timestamp":1788732523203,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41440-026-02731-4","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:59:08Z","timestamp":1783407548000},"page":"2561-2571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral contraceptive-associated hypertension as an under-recognized contributor to secondary and apparent resistant hypertension: agent-specific blood pressure liability, RAAS testing pitfalls, and practical assessment"],"prefix":"10.1038","volume":"49","author":[{"given":"Yoshitaka","family":"Furuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Namikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2731_CR1","doi-asserted-by":"publisher","unstructured":"Daniels K, Abma JC. Current contraceptive status among females ages 15-49: United States, 2022\u20132023. NCHS Data Brief. 2025;1\u201311. https:\/\/doi.org\/10.15620\/cdc\/174618.","DOI":"10.15620\/cdc\/174618"},{"key":"2731_CR2","doi-asserted-by":"publisher","first-page":"e0327774","DOI":"10.1371\/journal.pone.0327774","volume":"20","author":"M Nakao","year":"2025","unstructured":"Nakao M, Kuwaki K, Yamauchi K, Nomura K, Tanihara S. Trends in the estimated proportion of outpatients with menstrual disorders and the number of prescribed low-dose estrogen\/progestin drugs in Japan: a descriptive study. PLoS One. 2025;20:e0327774 https:\/\/doi.org\/10.1371\/journal.pone.0327774.","journal-title":"PLoS One"},{"key":"2731_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jog.70093","volume":"51","author":"K Takata","year":"2025","unstructured":"Takata K, Ogawa M, Takahashi T. Temporal trends and determinants of low-dose estrogen-progestin prescription in Japan during 2014-2022: an ecological study using a nationwide claims database. J Obstet Gynaecol Res. 2025;51:e70093. https:\/\/doi.org\/10.1111\/jog.70093.","journal-title":"J Obstet Gynaecol Res"},{"key":"2731_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.122.20018","volume":"80","author":"NA Cameron","year":"2023","unstructured":"Cameron NA, Blyler CA, Bello NA. Oral contraceptive pills and hypertension: a review of current evidence and recommendations. Hypertension. 2023;80:924\u201335. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.20018.","journal-title":"Hypertension"},{"key":"2731_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurox.2024.100307","volume":"22","author":"IS de Souza","year":"2024","unstructured":"de Souza IS, Laporta GZ, Zangirolami-Raimundo J, Sorpreso ICE, Silva dos Santos HCL, Soares J\u00fanior JM, et al. Association between the use of oral contraceptives and the occurrence of systemic hypertension: a systematic review with statistical comparison between randomized clinical trial interventions. Eur J Obstet Gynecol Reprod Biol X. 2024;22:100307. https:\/\/doi.org\/10.1016\/j.eurox.2024.100307.","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"2731_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","volume":"73","author":"AT Nguyen","year":"2024","unstructured":"Nguyen AT, Curtis KM, Tepper NK, Kortsmit K, Brittain AW, Snyder EM, et al. U.S. medical eligibility criteria for contraceptive use, 2024. MMWR Recomm Rep. 2024;73:1\u2013126. https:\/\/doi.org\/10.15585\/mmwr.rr7304a1.","journal-title":"MMWR Recomm Rep"},{"key":"2731_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.cir.94.3.483","volume":"94","author":"L Chasan-Taber","year":"1996","unstructured":"Chasan-Taber L, Willett WC, Manson JE, Spiegelman D, Hunter DJ, Curhan G, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 1996;94:483\u20139. https:\/\/doi.org\/10.1161\/01.cir.94.3.483.","journal-title":"Circulation"},{"key":"2731_CR8","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/jch.13042","volume":"19","author":"H Liu","year":"2017","unstructured":"Liu H, Yao J, Wang W, Zhang D. Association between duration of oral contraceptive use and risk of hypertension: a meta-analysis. J Clin Hypertens. 2017;19:1032\u201341. https:\/\/doi.org\/10.1111\/jch.13042.","journal-title":"J Clin Hypertens"},{"key":"2731_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0010-7824(02)00429-8","volume":"67","author":"JN Lubianca","year":"2003","unstructured":"Lubianca JN, Faccin CS, Fuchs FD. Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women. Contraception. 2003;67:19\u201324. https:\/\/doi.org\/10.1016\/s0010-7824(02)00429-8.","journal-title":"Contraception"},{"key":"2731_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jhh.1001841","volume":"19","author":"JN Lubianca","year":"2005","unstructured":"Lubianca JN, Moreira LB, Gus M, Fuchs FD. Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension. J Hum Hypertens. 2005;19:451\u20135. https:\/\/doi.org\/10.1038\/sj.jhh.1001841.","journal-title":"J Hum Hypertens"},{"key":"2731_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0010-7824(95)00153-2","volume":"52","author":"IF Godsland","year":"1995","unstructured":"Godsland IF, Crook D, Devenport M, Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception. 1995;52:143\u20139. https:\/\/doi.org\/10.1016\/0010-7824(95)00153-2.","journal-title":"Contraception"},{"key":"2731_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.contraception.2012.12.002","volume":"88","author":"A Cagnacci","year":"2013","unstructured":"Cagnacci A, Ferrari S, Napolitano A, Piacenti I, Arangino S, Volpe A. Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study. Contraception. 2013;88:413\u20137. https:\/\/doi.org\/10.1016\/j.contraception.2012.12.002.","journal-title":"Contraception"},{"key":"2731_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejogrb.2014.01.006","volume":"175","author":"MG Nisenbaum","year":"2014","unstructured":"Nisenbaum MG, de Melo NR, Giribela CR, de Morais TL, Guerra GM, de Angelis K, et al. Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial. Eur J Obstet Gynecol Reprod Biol. 2014;175:62\u201366. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.01.006.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2731_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MBP.0000000000000139","volume":"20","author":"MN de Nadai","year":"2015","unstructured":"de Nadai MN, Nobre F, Ferriani RA, Vieira CS. Effects of two contraceptives containing drospirenone on blood pressure in normotensive women: a randomized controlled trial. Blood Press Monit. 2015;20:310\u20135. https:\/\/doi.org\/10.1097\/MBP.0000000000000139.","journal-title":"Blood Press Monit"},{"key":"2731_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.contraception.2014.05.011","volume":"90","author":"G Grandi","year":"2014","unstructured":"Grandi G, Xholli A, Napolitano A, Piacenti I, Bellafronte M, Cagnacci A. Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol. Contraception. 2014;90:529\u201334. https:\/\/doi.org\/10.1016\/j.contraception.2014.05.011.","journal-title":"Contraception"},{"key":"2731_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.contraception.2021.01.001","volume":"103","author":"C Klipping","year":"2021","unstructured":"Klipping C, Duijkers I, Mawet M, Maillard C, Bastidas A, Jost M, et al. Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone. Contraception. 2021;103:213\u201321. https:\/\/doi.org\/10.1016\/j.contraception.2021.01.001.","journal-title":"Contraception"},{"key":"2731_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.contraception.2003.09.002","volume":"69","author":"SF Hussain","year":"2004","unstructured":"Hussain SF. Progestogen-only pills and high blood pressure: is there an association? A literature review. Contraception. 2004;69:89\u201397. https:\/\/doi.org\/10.1016\/j.contraception.2003.09.002.","journal-title":"Contraception"},{"key":"2731_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.conx.2020.100020","volume":"2","author":"T Kimble","year":"2020","unstructured":"Kimble T, Burke AE, Barnhart KT, Archer DF, Colli E, Westhoff CL. A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24\/4-day regimen. Contracept X. 2020;2:100020. https:\/\/doi.org\/10.1016\/j.conx.2020.100020.","journal-title":"Contracept X"},{"key":"2731_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.contraception.2008.06.012","volume":"78","author":"J Loughlin","year":"2008","unstructured":"Loughlin J, Seeger JD, Eng PM, Foegh M, Clifford CR, Cutone J, et al. Risk of hyperkalemia in women taking ethinylestradiol\/drospirenone and other oral contraceptives. Contraception. 2008;78:377\u201383. https:\/\/doi.org\/10.1016\/j.contraception.2008.06.012.","journal-title":"Contraception"},{"key":"2731_CR20","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15267","volume":"10","author":"CZ Kalenga","year":"2022","unstructured":"Kalenga CZ, Dumanski SM, Metcalfe A, Robert M, Nerenberg KA, MacRae JM, et al. The effect of non-oral hormonal contraceptives on hypertension and blood pressure: a systematic review and meta-analysis. Physiol Rep. 2022;10:e15267. https:\/\/doi.org\/10.14814\/phy2.15267.","journal-title":"Physiol Rep"},{"key":"2731_CR21","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72:e53\u2013e90. https:\/\/doi.org\/10.1161\/HYP.0000000000000084.","journal-title":"Hypertension"},{"key":"2731_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s0020-7292(97)00239-7","volume":"59","author":"F Cardoso","year":"1997","unstructured":"Cardoso F, Polonia J, Santos A, Silva-Carvalho J, Ferreira-de-Almeida J. Low-dose oral contraceptives and 24-hour ambulatory blood pressure. Int J Gynaecol Obstet. 1997;59:237\u201343. https:\/\/doi.org\/10.1016\/s0020-7292(97)00239-7.","journal-title":"Int J Gynaecol Obstet"},{"key":"2731_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0895-7061(95)96212-3","volume":"8","author":"K Narkiewicz","year":"1995","unstructured":"Narkiewicz K, Graniero GR, D\u2019Este D, Mattarei M, Zonzin P, Palatini P. Ambulatory blood pressure in mild hypertensive women taking oral contraceptives: a case-control study. Am J Hypertens. 1995;8:249\u201353. https:\/\/doi.org\/10.1016\/0895-7061(95)96212-3.","journal-title":"Am J Hypertens"},{"key":"2731_CR24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2978","volume":"10","author":"D Mir","year":"2018","unstructured":"Mir D, Ardabilygazir A, Afshariyamchlou S, Sachmechi I. Malignant hypertension in association with low estrogen dose oral contraceptives: case report and review of literature. Cureus. 2018;10:e2978. https:\/\/doi.org\/10.7759\/cureus.2978.","journal-title":"Cureus"},{"key":"2731_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2169\/internalmedicine.55.5500","volume":"55","author":"N Suzuki","year":"2016","unstructured":"Suzuki N, Suzuki K, Mizuno T, Kato Y, Suga N, Yoshino M, et al. Hypertensive crisis and left ventricular thrombi after an upper respiratory infection during the long-term use of oral contraceptives. Intern Med. 2016;55:83\u201388. https:\/\/doi.org\/10.2169\/internalmedicine.55.5500.","journal-title":"Intern Med"},{"key":"2731_CR26","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1210\/jc.2010-2918","volume":"96","author":"AH Ahmed","year":"2011","unstructured":"Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J Clin Endocrinol Metab. 2011;96:1797\u2013804. https:\/\/doi.org\/10.1210\/jc.2010-2918.","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1210\/clinem\/dgad010","volume":"108","author":"J Yang","year":"2023","unstructured":"Yang J, Gwini SM, Beilin LJ, Schlaich M, Stowasser M, Young MJ, et al. Effect of oral contraception on screening tests for primary aldosteronism: a 10-year longitudinal study. J Clin Endocrinol Metab. 2023;108:1686\u201395. https:\/\/doi.org\/10.1210\/clinem\/dgad010.","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5837\/bjc.2020.009","volume":"27","author":"A Birkinshaw","year":"2020","unstructured":"Birkinshaw A, Sharma P, Han TS. Progestogen-only pill associates with false-positive aldosterone\/renin ratio screening test. Br J Cardiol. 2020;27:37\u201340. https:\/\/doi.org\/10.5837\/bjc.2020.009.","journal-title":"Br J Cardiol"},{"key":"2731_CR29","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","volume":"110","author":"GK Adler","year":"2025","unstructured":"Adler GK, Stowasser M, Correa RR, Khan N, Kline G, McGowan MJ, et al. Primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2025;110:2453\u201395. https:\/\/doi.org\/10.1210\/clinem\/dgaf284.","journal-title":"J Clin Endocrinol Metab"},{"key":"2731_CR30","doi-asserted-by":"publisher","first-page":"CD011054","DOI":"10.1002\/14651858.CD011054.pub2","volume":"2015","author":"RE Roach","year":"2015","unstructured":"Roach RE, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015;2015:CD011054 https:\/\/doi.org\/10.1002\/14651858.CD011054.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2731_CR31","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","volume":"366","author":"O Lidegaard","year":"2012","unstructured":"Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366:2257\u201366. https:\/\/doi.org\/10.1056\/NEJMoa1111840.","journal-title":"N Engl J Med"},{"key":"2731_CR32","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"key":"2731_CR33","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 206: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol. 2019;133:e128-e150.","DOI":"10.1097\/AOG.0000000000003072"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02731-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:03:49Z","timestamp":1788732229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02731-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02731-4","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}